The LFA, in partnership with NIAD, will co-fund a study researching potential new lupus treatments.
A diagnostic test developed through research supported by the Foundation has found to be a reliable measure of lupus disease activity.
Foundation’s bridge-funding supported Dr. Jill Buyon’s lab at NYU-Langone to continue study on pregnancy and lupus
A recently published study concludes that lupus is among the leading causes of death for women in the U.S.
New Study Seeks to Determine Effectiveness of Synthetic Cannabinoid in Relieving Joint Pain in Lupus
A new clinical trial is underway to test the efficacy efficacy of a synthetic cannabinoid derivative for joint pain.
Results from a Phase IIb 24-week clinical trial show that Atacicect is safe and may benefit people with high levels of disease activity.
$3.8 million committed by the Lupus Foundation of America to support first-of-its-kind research.
Dr. Rosalind Ramsey-Goldman and Dr. José Crispín are recognized by the Lupus Foundation of America for their achievements in lupus research.